Kidney Cancer Trends, Risk Factors, and Interventions in American Indian and Alaska Native Populations
IKCS-NA 2025
Salvatore La Rosa, Pavlos Msaouel, AJ Sedgewick, Nathan Maulding, Alejandro Recio Boiles, Ken Batai
Abstract
American Indian and Alaska Native (AI/AN) populations experience disproportionately high kidney cancer incidence and mortality rates compared to other U.S. groups. Literature was reviewed to explore the factors contributing to the unequally higher kidney cancer burden in AI/AN communities and to develop recommendations to reduce these disparities. The incidence of kidney cancer has been rising over the past few decades, and this increase has been especially steep among AI/AN individuals. Death rates in AI/AN populations are roughly twice those of the non-Hispanic White population. The elevated kidney cancer burden in AI/AN may be driven by both clinical risk factors (obesity, diabetes, hypertension, chronic kidney disease, smoking, and environmental factors) and structural determinants of health which can critically shape these disparities. Chronic health conditions and smoking are linked to poverty and education level. AI/AN communities have high uninsured rates, and the Indian Health Services is chronically underfunded. Systemic inequalities limit AI/AN patients and community members’ access to chronic disease management, smoking cessation programs, primary and specialty care for early detection, and ultimately, treatment. AI/AN patients may have mistrust or other cultural barriers to engaging with the healthcare system and providers, while implicit bias in healthcare providers may lead to undertreatment, key interventions and tailored programs aimed at reducing kidney cancer incidence and mortality are needed. Here we will highlight some current interventions, including access to disease management and smoking cessation programs; facilitating health care access and quality; adopting patient navigation and culturally competent education; and developing strategies for early detection, such as screening in high-risk populations. In partnership with AI/AN communities, a combination of prevention, early detection, and healthcare system improvements is needed to close the kidney cancer gap between AI/AN and other populations.
Related publications